Risk of active tuberculosis and herpes zoster with tumor necrosis factor inhibitor treatment in adults with autoimmune disease conditions: a systematic trial sequential analysis of randomized placebo-controlled clinical trials
- DOI
- 10.1080/14740338.2026.2642872
- Published
- 2026-03-11
- Container
- Expert Opinion on Drug Safety
- Publisher
- Informa UK Limited
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1080/14740338.2026.2642872,
title = {Risk of active tuberculosis and herpes zoster with tumor necrosis factor inhibitor treatment in adults with autoimmune disease conditions: a systematic trial sequential analysis of randomized placebo-controlled clinical trials},
author = {George N. Okoli and Benjamin J. Cowling and Nicole Askin and Diane M. Harper and Paul Van Caeseele},
year = {2026},
journal = {Expert Opinion on Drug Safety},
doi = {10.1080/14740338.2026.2642872},
url = {https://doi.org/10.1080/14740338.2026.2642872}
}RIS
TY - JOUR TI - Risk of active tuberculosis and herpes zoster with tumor necrosis factor inhibitor treatment in adults with autoimmune disease conditions: a systematic trial sequential analysis of randomized placebo-controlled clinical trials AU - George N. Okoli AU - Benjamin J. Cowling AU - Nicole Askin AU - Diane M. Harper AU - Paul Van Caeseele PY - 2026 JO - Expert Opinion on Drug Safety DO - 10.1080/14740338.2026.2642872 UR - https://doi.org/10.1080/14740338.2026.2642872 ER -
APA
Okoli, G. N., Cowling, B. J., Askin, N., Harper, D. M., & Caeseele, P. V. (2026). Risk of active tuberculosis and herpes zoster with tumor necrosis factor inhibitor treatment in adults with autoimmune disease conditions: a systematic trial sequential analysis of randomized placebo-controlled clinical trials. Expert Opinion on Drug Safety. https://doi.org/10.1080/14740338.2026.2642872
Source records
- crossref · retrieved 2026-09-25T10:56:14.550Z